APPLE CIDER VINEGAR SHOT BRAND BUSINESS PLAN
I. Executive Summary
Company Description
The company name is not provided. Founded for a 2026 U.S. launch, we operate in the consumer wellness and specialty beverage sector producing premium, 2oz organic apple cider vinegar wellness shots. Our product line uses USDA organic ingredients and functional botanical blends, and we manufacture from a central facility located in a major U.S. wellness hub to stay close to target customers and retail partners.
We sell direct-to-consumer via e-commerce and through strategic wholesale distribution in the health and fitness channels. Our advantages are product quality, certified organic sourcing, and compact, daily-dose convenience aimed at modern wellness consumers aged 25–45. Short-term goals: execute the 2026 launch, build a DTC revenue base, and secure initial wholesale accounts. Long-term goals: scale national wholesale distribution, expand SKUs, and achieve sustainable margins through operational efficiency.
Problem
Health-conscious consumers hesitate to use apple cider vinegar (ACV) because of its harsh, acidic taste, which creates a sensory barrier and reduces adoption even among people who want ACV’s reported benefits.
Current routines force users to measure and mix liquid vinegar at home or work, creating time cost, spills, and inconsistent dosing. Many ready-made wellness beverages contain high sugar or artificial additives that negate ACV’s intended effects.
Busy professionals and fitness enthusiasts lack a convenient, high-potency, portable ACV option with organic ingredients and functional blends (for example, turmeric). There is no widely available 2oz, USDA organic, ready-to-drink ACV shot that solves taste, dosing, portability, and clean-ingredient needs.
Solution
Ready-to-drink, 2oz USDA organic apple cider vinegar shots pair unfiltered ACV (with the "Mother") and natural fruit juices plus functional botanicals to solve taste, convenience, and clean-label gaps. Many health-conscious consumers avoid ACV due to flavor and prep; these compact shots deliver full-strength benefits without dilution, artificial ingredients, or excess sugar.
The lineup includes turmeric-ginger, elderberry, lemon-cayenne, matcha energy, and pure original—designed for gym bags, office desks, and daily routines to provide recovery, immune support, digestion/metabolism aid, natural caffeine, or classic ACV benefits. One pack, one shot, ready-to-use.
Mission Statement
Our mission is to empower individuals on their wellness journeys by making the most delicious and effective organic functional shots that simplify daily health habits and support a vibrant lifestyle. We commit to 100% USDA organic ingredients, full transparency, and sustainable practices to protect customer health and the planet. We innovate within the functional beverage category to make powerful natural remedies like apple cider vinegar enjoyable, convenient, and accessible to the modern, health-focused consumer.
Key Success Factors
These core advantages drive our growth, margins, and recurring revenue.
-
Proprietary flavor profile — widely considered the best-tasting ACV shot in the industry.
-
100% USDA organic certification — guarantees product trust and premium pricing.
-
Benefit-driven functional blends — differentiates on health outcomes and repeat use.
-
Multi-channel distribution — direct-to-consumer, retail, and fitness platforms ensure visibility and accessibility.
-
Strong unit economics — 14-month break-even and 28-month payback support sustainable growth and subscription retention.
Financial Summary
Brief financial summary for the Executive Summary: five-year revenue scales from $350,000 in 2026 to $3,700,000 in 2030 with rapid EBITDA recovery and a February 2027 break-even.
Ratio | 2026 | 2027 | 2028 |
Projected Revenue | $350,000 | $799,000 | $1,440,000 |
Projected EBITDA | -$82,000 | $185,000 | $1,159,000 |
Expected ROI | 7.4% IRR / 6.64% ROE | 7.4% IRR / 6.64% ROE | 7.4% IRR / 6.64% ROE |
Financial requirements: minimum cash cushion of $1,032,000 to cover operations to break-even (Feb-27). Total planned capex is $197,000. Anticipated return metrics: IRR 7.4% and ROE 6.64%; payback targeted in 28 months.
Overall outlook: revenue and EBITDA scale strongly, with break-even in Feb 2027 and positive investor returns.
Funding Requirements
We require $1,032,000 in total capital to launch, fund the initial production run, cover branding and website, and provide working capital through break-even in Feb-2027.
Categories | Amount, USD |
Product development (bottling, IT, lab) | $97,000 |
Production & initial inventory (including racking) | $55,000 |
Branding & DTC website | $45,000 |
Marketing | $0 |
Operations (fixed costs pre-revenue) | $0 |
Staffing (salaries funded by working capital) | $0 |
Other CAPEX (as listed) | $0 |
Working capital | $835,000 |
Total funding required | $1,032,000 |